Clover Health to Report Third Quarter 2024 Financial Results on November 6
23 Ottobre 2024 - 10:05PM
Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”),
today announced that it will report third quarter 2024 financial
results after market close on Wednesday, November 6, 2024.
Management will host a conference call and webcast at 5:00 p.m.
Eastern Time on November 6, 2024, to discuss Clover Health’s third
quarter 2024 business and financial results.
Third Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health’s Third Quarter 2024 Earnings Conference
Call
- When: Wednesday, November 6, 2024, at 5:00 p.m. Eastern
Time
- Dial In: To access the call via telephone please dial
800-579-2543 (for U.S. callers) or 785-424-1789 (for callers
outside the U.S.) and enter the conference ID: CLOVQ324
- Webcast: A live and archived webcast of the conference call
will be accessible from the Investor Relations section of Clover
Health’s website at https://investors.cloverhealth.com/ for 12
months
About Clover Health:Clover Health (Nasdaq:
CLOV) is a physician enablement technology company committed to
bringing access to great healthcare to everyone on Medicare. This
includes a health equity-based focus on seniors who have
historically lacked access to affordable, high-quality healthcare.
Our strategy is powered by our software platform, Clover Assistant,
which is designed to aggregate patient data from across the
healthcare ecosystem to support clinical decision-making and
improve health outcomes through the early identification and
management of chronic disease. For our members, we provide PPO and
HMO Medicare Advantage plans in several states, with a
differentiated focus on our flagship wide-network, high-choice PPO
plans. For healthcare providers outside Clover Health's Medicare
Advantage plan, we aim to extend the benefits of our data-driven
technology platform to a wider audience via our subsidiary,
Counterpart Health, and to enable enhanced patient outcomes and
reduced healthcare costs on a nationwide scale. Clover Health has
published data demonstrating the technology’s impact on Medication
Adherence, as well as the earlier identification and management of
Diabetes and Chronic Kidney Disease.
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations Contact:Ryan
Schmidtinvestors@cloverhealth.com
Grafico Azioni Clover Health Investments (NASDAQ:CLOV)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Clover Health Investments (NASDAQ:CLOV)
Storico
Da Dic 2023 a Dic 2024